BeStock  
Stocks › Biotechnology › PHAT

Phathom Pharmaceuticals PHAT

US equityMarket cap rank #3686Biotechnology
$4.66 −$0.42 (-8.27%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $4.66 0.00%
Open$4.93
Prev close$5.08
Day range$4.62 – $5.15
Volume1.33M
Market cap$378.82M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership89.5%-4.28 pts vs. prior quarter
Institutions holding200+1 vs. prior quarter
Insider trades (recent)31 buys / 19 sellsNet buying
Short interest11.32% of floatDays to cover 4.8 · as of 30 Oct 2026
Short-sale volume share21.2%5-day average of daily volume

Short-sale volume as % of daily volume

12%19%26%33%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$3.61M (9 inflow days, 11 outflow days).

Net flow by order size, last 20 sessions

−$3.2MSuper−$365.5KBig−$1.1MMid−$370.8KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 40.2% of shares outstanding.

Largest holders

  • Frazier Life Sciences Management, LP15.34%
  • Medicxi Ventures (UK) LLP9.18%
  • BlackRock6.45%
  • Invesco Ltd.4.98%
  • Abingworth LLP4.30%
  • Millennium Management LLC4.15%
  • Wasatch Advisors LP3.62%
  • Vanguard Capital Management, LLC3.36%

By investor type

  • Mutual Fund36.49%
  • VC/PE Fund34.78%
  • Hedge Fund13.77%
  • Individual/Insider3.54%
  • Public Company2.76%
  • Endowment Fund1.00%
  • Private Company0.27%
  • Government Pension Fund0.21%

Reported short interest has fallen from 14.55% to 11.32% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Sanjeev Narula Individual/Insider 2026/Q3 +215,841 0.3%
Wasatch Advisors LP Mutual Fund 2026/Q3 +1,635,185 3.6%
BlackRock Mutual Fund 2026/Q3 +721,131 6.5%
Franklin Resources Mutual Fund 2026/Q3 +435,585 3.0%
State Street Global Advisors Mutual Fund 2026/Q3 +411,553 2.5%
Catalys Pacific VC/PE Fund 2026/Q3 +388,185 2.3%
BNP Paribas Financial Markets SNC Private Company 2026/Q3 +187,594 0.2%
UBS Asset Management Mutual Fund 2026/Q3 +171,804 0.5%
Squarepoint OPS LLC Hedge Fund 2026/Q3 +109,006 0.2%
ProFund Advisors LLC Mutual Fund 2026/Q3 +104,054 0.1%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +119,285 0.1%
Point72 Asset Management, L.P. Hedge Fund 2026/Q3 +1,022,193 1.3%
Franklin Resources Mutual Fund 2026/Q3 +976,324 2.4%
The Goldman Sachs Group, Inc. Public Company 2026/Q3 +893,022 1.8%
GW&K Investment Management, LLC Mutual Fund 2026/Q3 +745,729 2.7%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
5 Oct 2026 Sanjeev Narula Chief Financial & Business Officer Sale to Issuer -13,485 $6.78 37,126
2 Sep 2026 Robert Breedlove Sale to Issuer -460 $9.05 67,657
13 Jul 2026 Robert Breedlove Sale to Issuer -1,555 $11.04 66,870
21 May 2026 Asit Parikh Independent Director Other Acquisition +28,000 – 148,500
21 May 2026 Asit Parikh Independent Director Other Disposition -28,000 – 148,500
19 May 2026 Asit Parikh Independent Director Derivative Sale to Issuer -17,500 – –
19 May 2026 Asit Parikh Independent Director Derivative Exercise and Retained +17,500 $4.95 148,500
18 May 2026 Michael Cola Independent chairman of the Board Other Acquisition +24,122 – 54,122
18 May 2026 Heidi Fields Independent Director Other Acquisition +24,122 – 34,622
18 May 2026 James Topper Independent Director Other Acquisition +24,122 – 24,122
18 May 2026 Frank Karbe Independent Director Other Acquisition +24,122 – 34,622
18 May 2026 Theodore Schroeder Independent Director Other Acquisition +24,122 – 38,122
18 May 2026 Asit Parikh Independent Director Other Acquisition +24,122 – 24,122
18 May 2026 Mark Stenhouse Independent Director Other Acquisition +24,122 – 34,622
9 Mar 2026 Asit Parikh Independent Director Other Acquisition +40,000 – 120,500
9 Mar 2026 Asit Parikh Independent Director Other Disposition -40,000 – 120,500
26 Feb 2026 Robert Breedlove Sale to Issuer -1,378 $12.56 55,425
26 Feb 2026 Robert Breedlove Other Acquisition +2,790 – 55,425
26 Feb 2026 Robert Breedlove Other Acquisition +13,000 – 13,000
9 Feb 2026 Steven Basta Chief Executive Officer Sale to Issuer -6,277 $12.82 122,281

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 9,204,035 11.3% 4.8
15 Oct 2026 9,784,183 12.1% 6.9
30 Sep 2026 10,109,151 12.5% 7.4
15 Sep 2026 10,157,209 12.6% 9.1
31 Aug 2026 10,823,977 13.4% 11.0
14 Aug 2026 11,773,979 14.6% 6.9

Discussion

No comments yet — be the first to weigh in on PHAT.

Sign in to join the discussion.

Scroll to Top